UPDATE: Citigroup Raises Target on AmSurg to $33

Citigroup raises its taget price on Buy-rated AmSurg AMSG to $33, up $2, as it updates the company's model for 2012-2014. Citigroup says, "4Q11 normalized results were slightly better than consensus and SS revs/vols were stable at +1% yty despite a tougher sequential comparison. We are making few changes to our model but expect market confidence to improve given the 2012 guidance. We are raising our 12-month target from $31 to $33 to reflect our net estimate changes and small-cap valuation appreciation since our last note." AMSG closed at $26.17 a share on Thursday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorPrice TargetReiterationPre-Market OutlookAnalyst RatingsCitigroup
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!